Nanollose Ltd

As of June 30, 2025, Nanollose Ltd carries a market capitalization of 20.44M, placing it among publicly traded companies globally. Its enterprise value stands at 19.84M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2025, Nanollose Ltd has 305.07M shares outstanding.

These figures are as of June 30, 2025.

As of June 30, 2025, Nanollose Ltd maintains a current ratio of 2.07, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.30, indicating elevated leverage, while an interest coverage ratio of -45.73 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2025. Return on assets (ROA) is negative at -288.25, reflecting losses generated across the asset base.

As of the close on October 20, 2026, Nanollose Ltd's stock has gained approximately 54.00% over the past 52 weeks. The 50-day moving average sits at 0.08, while the 200-day moving average is 0.07.

These figures cover the twelve months ended June 30, 2025. EBITDA reached -1.60M, while operating income came in at -1.63M.

As of June 30, 2025, Nanollose Ltd holds 617,318.00 in cash and equivalents against 13,086.00 in total debt, resulting in a net debt position of -617,318.00. Total book value stands at 396,411.00, with working capital of 376,184.00 providing operational flexibility.

These figures cover the twelve months ended June 30, 2025. Total shareholder yield is negative at -7.72, meaning Nanollose Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Nanollose Ltd's most recent stock split took place on January 20, 2025 with a 35:36 split ratio.